penile cancer (Cancer)
Information
- Disease name
- penile cancer
- Disease ID
- DOID:11615
- Description
Disease area statistics
Chromosome band
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04231981 | Active, not recruiting | Phase 2 | Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma (ORPHEUS) | April 28, 2020 | December 31, 2023 |
| NCT03333616 | Active, not recruiting | Phase 2 | Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors | December 28, 2017 | May 31, 2025 |
| NCT04357873 | Active, not recruiting | Phase 2 | Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations | October 28, 2020 | January 2025 |
| NCT00512096 | Completed | Phase 2 | Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis | August 1999 | August 2010 |
| NCT01209325 | Completed | Phase 2 | Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males | June 28, 2011 | December 12, 2017 |
| NCT01585428 | Completed | Phase 2 | Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers | April 13, 2012 | August 1, 2016 |
| NCT02280811 | Completed | Phase 1/Phase 2 | T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers | October 14, 2014 | June 28, 2016 |
| NCT00002506 | Completed | Phase 2 | Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | August 1992 | February 1999 |
| NCT00019110 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer | November 1995 | |
| NCT00066391 | Completed | Phase 2 | Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer | June 2003 | |
| NCT03346915 | Completed | N/A | Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention | August 14, 2018 | April 19, 2019 |
| NCT03686332 | Completed | Phase 2 | PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study | September 25, 2018 | September 15, 2023 |
| NCT03856437 | Completed | N/A | A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination | January 22, 2021 | April 15, 2022 |
| NCT04475016 | Completed | Phase 2 | TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer | August 12, 2020 | May 30, 2022 |
| NCT04574427 | Completed | INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue | November 13, 2019 | November 14, 2020 | |
| NCT05376202 | Completed | Phase 1 | Image Guided Penile Cancer Surgery | March 7, 2022 | April 14, 2024 |
| NCT05518201 | Completed | Phase 1 | Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old | September 23, 2022 | November 20, 2023 |
| NCT05887921 | Completed | N/A | Inguinal Lymphadenectomy for Penile Cancer | April 30, 2019 | May 24, 2023 |
| NCT05959564 | Completed | N/A | A Chatbot Intervention for Reducing HPV Vaccine Hesitancy | July 26, 2023 | August 8, 2023 |
| NCT05662839 | Not yet recruiting | N/A | Feasibility of Utilising Brushing Cytology and Dermoscopy for Diagnosing Penile Lesions | January 2023 | January 2024 |
| NCT06415318 | Not yet recruiting | Phase 2 | TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer | June 1, 2024 | December 1, 2027 |
| NCT06353906 | Not yet recruiting | Phase 2 | Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer | June 14, 2024 | January 14, 2028 |
| NCT05639972 | Not yet recruiting | Phase 1/Phase 2 | E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers | June 12, 2024 | October 1, 2026 |
| NCT05946993 | Recruiting | N/A | Linking In With Advice and Supports for Men Impacted by Metastatic Cancer | May 8, 2023 | April 2025 |
| NCT05447273 | Recruiting | The Role of Functional Magnetic Resonance Imaging in Preoperative Assessment of Primary Penile Carcinoma | July 15, 2022 | January 2030 | |
| NCT05592639 | Recruiting | N/A | VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer | June 23, 2022 | August 1, 2024 |
| NCT04028479 | Recruiting | The Registry of Oncology Outcomes Associated With Testing and Treatment | May 5, 2021 | October 1, 2031 | |
| NCT05899361 | Recruiting | N/A | A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest | August 30, 2023 | December 25, 2026 |
| NCT04708470 | Recruiting | Phase 1/Phase 2 | A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers | October 5, 2021 | December 31, 2025 |
| NCT05264337 | Recruiting | Lymphedema After Urologic Surgery | March 14, 2022 | January 2030 | |
| NCT03774901 | Recruiting | Phase 2 | Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma | March 12, 2019 | September 22, 2024 |
| NCT05842031 | Recruiting | Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer | April 14, 2023 | December 31, 2026 | |
| NCT02817958 | Recruiting | Phase 2 | Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis | October 17, 2016 | September 2028 |
| NCT02994758 | Recruiting | N/A | Development of Diagnostics and Treatment of Urological Cancers | November 27, 2017 | December 2025 |
| NCT02012699 | Recruiting | Integrated Cancer Repository for Cancer Research | November 1, 2013 | December 2099 | |
| NCT05686226 | Recruiting | Phase 2 | E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers | March 7, 2023 | January 1, 2025 |
| NCT03391479 | Recruiting | Phase 2 | A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy | August 15, 2018 | December 31, 2024 |
| NCT05739812 | Recruiting | N/A | The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery | February 5, 2023 | April 2024 |
| NCT00058448 | Terminated | Phase 2 | S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED) | October 2004 | November 2005 |
| NCT00955929 | Terminated | N/A | Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy | August 6, 2009 | December 9, 2020 |
- Disase is a (Disease Ontology)
- DOID:3856
- Cross Reference ID (Disease Ontology)
- ICD10CM:C60
- Cross Reference ID (Disease Ontology)
- ICD10CM:C60.2
- Cross Reference ID (Disease Ontology)
- ICD9CM:187.3
- Cross Reference ID (Disease Ontology)
- ICD9CM:187.4
- Cross Reference ID (Disease Ontology)
- MESH:D010412
- Cross Reference ID (Disease Ontology)
- NCI:C7547
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:93716006
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:93954003
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0153600
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0153601
- Exact Synonym (Disease Ontology)
- Ca penis
- Exact Synonym (Disease Ontology)
- malignant neoplasm of body of penis
- Exact Synonym (Disease Ontology)
- malignant Penile tumor
- Exact Synonym (Disease Ontology)
- Penile Ca
- Exact Synonym (Disease Ontology)
- penile neoplasm